FDA Drug Recalls

Recalls / Class III

Class IIID-0243-2015

Product

Candesartan Cilexetil Tablets, 16 mg, a) 30-count bottle (NDC 60505-3620-3) b) 90-count bottles (NDC 60505-3620-9) Rx Only, Manufactured by Apotex Research Pvt. Ltd., Bangalore- 560 099, India, Manufactured for Apotex Corp., Weston, FL 33326

Affected lot / code info
Lot #: a) KR3943; Exp. 11/15 Lot #: b) KT6058, KT6060; Exp. Date 11/15

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.

Recalling firm

Firm
Apotex Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
150 Signet Drive, N/A, Toronto, N/A N/A, Canada

Distribution

Quantity
11,062 bottles
Distribution pattern
Nationwide.

Timeline

Recall initiated
2014-10-16
FDA classified
2014-11-06
Posted by FDA
2014-11-12
Terminated
2016-09-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0243-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls